Nektar Therapeutics (NASDAQ:NKTR)

3.06
Delayed Data
As of Sep 27
 -0.02 / -0.65%
Today’s Change
3.00
Today|||52-Week Range
19.37
-77.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-81.2M-153.5M-96.7M681.3M
 
 
 
 
 
Depreciation12.9M15.4M14.7M10.9M
 
 
 
 
 
Total Other Cash Flow29.9M13.2M39.2M65.0M
 
 
 
 
 
Funds From Operations-38.4M-125.0M-42.8M757.2M
 
 
 
 
 
Funds From/For Other Operating Expenses34.7M-7.9M37.6M39.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-73.1M-117.0M-80.4M718.2M
 
 
 
 
 
 
InvestingIncrease In Investments-297.6M-334.7M-404.4M-2.3B
 
 
 
 
 
Decrease In Investments269.5M258.7M385.3M902.9M
 
 
 
 
 
Capital Expenditures-11.2M-6.4M-9.7M-14.2M
 
 
 
 
 
Fixed Asset Disposal------2.6M
 
 
Net Cash Flow Investing-39.3M-82.4M-28.8M-1.4B
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings241.3M0.000.000.00
 
 
Long Term Debt Reduction-142.7M-5.9M-5.1M0.00
 
 
 
 
Net Proceeds Stock Sale32.2M209.6M59.5M852.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing130.8M203.6M54.4M852.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-159.0K-124.0K-46.0K-101.0K
 
 
 
 
 
 
Net Change In Cash18.4M4.2M-54.8M190.2M